MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$114,961K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Repayments of loans receivable
Provision for (recovery of) loan...
Net proceeds from the sales of r...
Others
Negative Cash Flow Breakdown
Acquisition of real estate and l...
Dividends paid on common stock
Net gain on sales of real estate
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
-25,248
40,813
27,147
128,363
Depreciation and amortization
56,379
53,131
51,405
48,511
Non-cash rental and related revenues
-3,654
-1,599
-1,840
7,151
Non-cash interest income
-1
0
0
0
Non-cash interest expense
2,370
2,368
2,362
2,153
Stock-based compensation expense
4,089
3,098
3,070
2,875
Loss on extinguishment of debt
-
-
0
-1,154
Provision for (recovery of) loan losses and other reserves
102,445
-213
-407
-240
Net gain on sales of real estate
37,717
-
-9,063
-4,430
Impairment of real estate
0
440
648
2,571
Income from unconsolidated joint ventures
2,224
1,912
1,652
1,226
Distributions of earnings from unconsolidated joint ventures
2,563
1,657
1,896
1,895
Other non-cash items
0
-
0
0
Accounts receivable, prepaid expenses and other assets, net
10,388
1,534
2,320
2,262
Accounts payable and accrued liabilities
-2,796
2,113
-1,945
10,435
Net cash provided by operating activities
85,820
98,362
87,427
99,964
Acquisition of real estate and lease intangibles
196,428
96,101
151,370
240,426
Origination and fundings of loans receivable
994
0
1,200
2,600
Origination and fundings of preferred equity investments
654
15
0
0
Additions to real estate
13,309
11,851
17,338
10,614
Escrow deposits for potential investments
-30
-70
-
500
Repayments of loans receivable
203,137
1,944
5,229
8,394
Repayments of preferred equity investments
-1,090
-1,256
-556
-608
Investment in unconsolidated joint ventures
0
0
0
0
Net proceeds from the sales of real estate
93,601
-
45,550
39,514
Net proceeds from sales-type lease
-
-
0
-
Proceeds from net investment hedges
0
-
0
0
Insurance proceeds
29
107
322
229
Distributions in excess of earnings from unconsolidated joint ventures
-
-
1,205
5,557
Net cash used in investing activities
86,502
-105,090
-116,546
-199,838
Net borrowings from revolving credit facility
-37,000
137,800
-65,000
174,805
Principal payments on senior unsecured notes
-
-
0
500,000
Proceeds from term loans
-
-
0
500,000
Principal payments on secured debt
535
531
527
524
Payments of deferred financing costs
0
92
0
4,325
Payments related to extinguishment of debt
-
-
0
2,884
Contributions from noncontrolling interests
-2
4
6
2,040
Distributions to noncontrolling interests
119
-
-
-
Payment of contingent consideration
0
1,178
0
-
Issuance of common stock, net
55,952
-8,247
39,431
164,139
Dividends paid on common stock
75,657
75,657
74,805
71,938
Net cash used in financing activities
-57,361
52,099
-100,895
206,169
Net increase in cash, cash equivalents and restricted cash
114,961
45,371
-130,014
106,295
Effect of foreign currency translation on cash, cash equivalents and restricted cash
-72
-60
636
-245
Cash, cash equivalents and restricted cash, beginning of period
123,451
78,140
207,518
66,339
Cash, cash equivalents and restricted cash, end of period
238,340
123,451
78,140
207,518
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Repayments of loans
receivable
$203,137K
(2782.19%↑ Y/Y)
Provision for (recovery
of) loan losses and...
$102,445K
(25711.25%↑ Y/Y)
Net proceeds from
the sales of real...
$93,601K
(2519.68%↑ Y/Y)
Repayments of preferred
equity investments
-$1,090K
(20.38%↑ Y/Y)
Escrow deposits for
potential investments
-$30K
Insurance proceeds
$29K
(-97.21%↓ Y/Y)
Depreciation and
amortization
$56,379K
(-35.26%↓ Y/Y)
Stock-based compensation
expense
$4,089K
(-24.49%↓ Y/Y)
Distributions of earnings from
unconsolidated joint ventures
$2,563K
(-36.28%↓ Y/Y)
Non-cash interest
expense
$2,370K
(-31.40%↓ Y/Y)
Non-cash interest income
-$1K
(85.71%↑ Y/Y)
Net cash used in
investing activities
$86,502K
(240.48%↑ Y/Y)
Net cash provided by
operating activities
$85,820K
(-46.77%↓ Y/Y)
Canceled cashflow
$211,385K
Canceled cashflow
$82,027K
Net increase in
cash, cash...
$114,961K
(227.25%↑ Y/Y)
Canceled cashflow
$57,361K
Acquisition of real estate
and lease...
$196,428K
(221.29%↑ Y/Y)
Additions to real estate
$13,309K
(-1.92%↓ Y/Y)
Origination and fundings of
loans receivable
$994K
(-68.04%↓ Y/Y)
Origination and fundings of
preferred equity...
$654K
(7166.67%↑ Y/Y)
Net gain on sales of
real estate
$37,717K
(278.15%↑ Y/Y)
Net income
-$25,248K
(-123.85%↓ Y/Y)
Accounts receivable,
prepaid expenses and...
$10,388K
(51.27%↑ Y/Y)
Non-cash rental and
related revenues
-$3,654K
(42.28%↑ Y/Y)
Accounts payable and
accrued liabilities
-$2,796K
(59.44%↑ Y/Y)
Income from
unconsolidated joint ventures
$2,224K
(111.81%↑ Y/Y)
Issuance of common stock,
net
$55,952K
(131.10%↑ Y/Y)
Net cash used in
financing activities
-$57,361K
(11.09%↑ Y/Y)
Canceled cashflow
$55,952K
Dividends paid on common
stock
$75,657K
(-47.00%↓ Y/Y)
Net borrowings from
revolving credit facility
-$37,000K
(-167.10%↓ Y/Y)
Principal payments on
secured debt
$535K
(-48.46%↓ Y/Y)
Distributions to
noncontrolling interests
$119K
Contributions from
noncontrolling interests
-$2K
Buy us a coffee
Sabra Health Care REIT, Inc. (SBRA)
Sabra Health Care REIT, Inc. (SBRA)